Trial Profile
A Multi-centre, Randomised, Single Blind, Placebo Controlled, Parallel Group Study to Examine the Effect of Single Doses of SB-705498, a TRPV1 Receptor Antagonist, on Pain Following Third Molar Tooth Extraction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jul 2023
Price :
$35
*
At a glance
- Drugs GSK 705498 (Primary) ; Paracetamol/codeine
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 25 Nov 2006 New trial record.